1-4 of 4
Toshihiro Matsukawa, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Severe Adverse Events By First Line Tyrosine Kinase Inhibitors Decrease Survival Rate in Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Shuichi Ota, MD PhD, Toshihiro Matsukawa, MD PhD, Satoshi Yamamoto, MD, Shinichi Ito, MD, Motohiro Shindo, MD, Kazuya Sato, MD PhD, Takeshi Kondo, MD PhD, Tohru Takahashi, MD, Tsutomu Sato, MD PhD, Yasutaka Kakinoki, MD PhD, Hajime Kobayashi, MD, Mitsutoshi Kurosawa, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1898.
https://doi.org/10.1182/blood.V128.22.1898.1898
Published: 2016
Journal Articles

Monosomal Karyotype in Myeloid Malignancies Is Prognostically Worse Even After Allogeneic Hematopoietc Stem Cell Transplantaion; Results From Two Transplant Centers,

Minauchi Koichiro, MD, Akio Shigematsu, MD, PhD, Masanobu Nakata, MD, Toshihiro Matsukawa, MD, Koh Ebata, MD, Tomohiro Yamakawa, MD, Tomoyuki Saga, MD, Kanako Shima, MD, Makoto Ibata, MD, PhD, Junichi Sugita, MD, PhD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Masahiro Ogasawara, MD, Ph.D, Yoshio Kiyama, MD, Masahiro Imamura, MD, PhD, Naoki Kobayashi, MD, Ph.D
Journal: Blood
Blood (2011) 118 (21): 4154.
https://doi.org/10.1182/blood.V118.21.4154.4154
Published: 2011
Journal Articles

Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells

Masahiro Ogasawara, MD, Ph.D, Tomohiro Yamakawa, MD, Yuki Katsura, MD, Kanako Shima, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Koichiro Minauchi, MD, Masanobu Nakata, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Naoki Kobayashi, MD, Ph.D, Yoshio Kiyama, MD, Naoto Hirano, MD, Ph.D
Journal: Blood
Blood (2010) 116 (21): 2101.
https://doi.org/10.1182/blood.V116.21.2101.2101
Published: 2010
Journal Articles

Pre-Treatment Serum Soluble Interleukin-2 Receptor Value Significantly Predicts Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.

Shinsuke Noguchi, MD, Masanobu Nakata, MD, Kanako Shima, MD, Yuki Katsura, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Satomi Matsuoka, MD, Mizuha Kosugi, MD, Shiro Fujii, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Masahiro Ogasawara, MD, PhD, Yoshio Kiyama, MD, Masaharu Kasai, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3948.
https://doi.org/10.1182/blood.V114.22.3948.3948
Published: 2009